Lilly Japan Looks To New Launches As Zyprexa Challenge Looms
This article was originally published in PharmAsia News
Executive Summary
Eli Lilly Japan says it strengthened its position as its parent’s most important affiliate outside the US last year, and is looking to recent and upcoming product launches to help it overcome looming generic competition for its top seller.